Pure Bioscience, Inc. (PURE) Reports Q2 Loss of $0.05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 subdued as gains in banks offset AI jitters; Dow at one-month high
- Oil prices gain more than 3%, heading for weekly gain with focus on Middle East supply
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts PURE Hot Sheet
Join SI Premium – FREE
Pure Bioscience, Inc. (NASDAQ: PURE) reported Q2 EPS of ($0.05), versus ($0.07) reported last year. Revenue for the quarter came in at $221 thousand, versus $68 thousand reported last year.
For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.
For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Williams Trading Downgrades Birkenstock Holding plc (BIRK) to Sell, 'Stock Less Comfortable than the Shoes'
- Micron Technology stock drops on China chip news and labor dispute
- Cogent Communication (CCOI) said to utilize Evercore amid financing issues
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
